This episode explores how genetics influences the way individuals handle and respond to medicines. Pharmacogenetics is framed not as a futuristic add-on, but as an extension of everyday pharmacology—explaining why standard doses fail some patients, harm others, and work beautifully for a few. We focus on principles that clinicians can recognise and apply, even when formal genetic testing is unavailable.

Key takeaways you’ll build and reuse throughout the series:

* Genetic variation as a modifier, not a determinant: how genes shift probabilities rather than dictate outcomes.

* Metabolic phenotypes in practice: poor, intermediate, extensive, and ultra-rapid metabolisers—and why these labels matter clinically.

* Targets versus handling: differences between genes affecting drug metabolism, transport, and receptor response.

* When genetics becomes visible: classic examples where inherited variation reveals itself through toxicity or therapeutic failure.

* Precision with humility: how to integrate genetic insight into prescribing without overconfidence or reductionism.

This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe